Article
Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia
29 Dec 2003
Abstract excerpt
Mutations of fibroblast growth factor receptor 3 (FGFR3) are responsible for achondroplasia (ACH) and related dwarfing conditions in humans. The pathogenesis involves constitutive activation of FGFR3, which inhibits proliferation and differentiation of growth plate chondrocytes. Here we report that activating mutations in FGFR3 increase the stability of the receptor. Our results suggest that the mutations disrupt...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
